Drugs / DL - Lactic Acid
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01988558 | Dec 2013 → Aug 2016 | tonsillitis | Yali Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DL - Lactic Acid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01988558 ↗ |
| Known as | Tonsitin | “The study objectives are to evaluate Tonsitin™ (10% Lactic Acid) safety, tolerability and preliminary efficacy, as a potent treatment for Recurrent Tonsillitis in children.” NCT01988558 ↗ |